Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $4.83 million. The enterprise value is -$367,761.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APVO has 3.29 million shares outstanding.
| Current Share Class | 3.29M |
| Shares Outstanding | 3.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +912.23% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 15.51% |
| Float | 2.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.27 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -437.34% and return on invested capital (ROIC) is -145.20%.
| Return on Equity (ROE) | -437.34% |
| Return on Assets (ROA) | -99.45% |
| Return on Invested Capital (ROIC) | -145.20% |
| Return on Capital Employed (ROCE) | -226.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$649,324 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.26% in the last 52 weeks. The beta is 1.43, so APVO's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | -99.26% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 19.07 |
| Relative Strength Index (RSI) | 46.15 |
| Average Volume (20 Days) | 1,076,659 |
Short Selling Information
The latest short interest is 899,341, so 27.35% of the outstanding shares have been sold short.
| Short Interest | 899,341 |
| Short Previous Month | 1.39M |
| Short % of Shares Out | 27.35% |
| Short % of Float | 30.10% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.30M |
| Pretax Income | -24.03M |
| Net Income | -24.03M |
| EBITDA | -24.04M |
| EBIT | -24.30M |
| Earnings Per Share (EPS) | -$110.78 |
Full Income StatementBalance Sheet
The company has $9.41 million in cash and $4.21 million in debt, giving a net cash position of $5.20 million or $1.58 per share.
| Cash & Cash Equivalents | 9.41M |
| Total Debt | 4.21M |
| Net Cash | 5.20M |
| Net Cash Per Share | $1.58 |
| Equity (Book Value) | 6.52M |
| Book Value Per Share | 2.02 |
| Working Capital | 6.19M |
Full Balance SheetCash Flow
| Operating Cash Flow | -24.65M |
| Capital Expenditures | n/a |
| Free Cash Flow | -24.65M |
| FCF Per Share | -$7.50 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
